Consolidated Statements of Cash Flows $ in Millions	12 Months Ended
	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)
Cash flows from operating activities:
Net income	$ 531.4	$ 135.4	$ 294.5
Adjustments to reconcile net income to net cash provided by operating activities, net of acquired businesses:
Depreciation and amortization	213.4	193.1	174.1
Litigation charges, net	204.9	588.0	268.9
Restructuring and productivity initiative costs, net of payments	5.0	22.5	9.8
Asset impairments	1.2	4.5	6.8
Settlement of pre-existing relationship related to Medicon	0.0	49.6	0.0
Gain on previously held ownership share of Medicon	0.0	(25.5)	0.0
Gain on sale of investment	0.0	0.0	(7.1)
Acquired in-process research and development	0.0	0.0	2.6
Deferred income taxes	(65.4)	(45.1)	(26.9)
Share-based compensation	90.0	81.8	71.4
Inventory reserves and provision for doubtful accounts	24.0	27.4	23.3
Other items	(1.7)	4.2	4.2
Changes in assets and liabilities, net of acquired businesses:
Accounts receivable	(25.1)	(18.0)	21.3
Inventories	(83.7)	(33.1)	(53.9)
Current liabilities	(318.8)	(217.3)	(35.0)
Taxes	(12.9)	22.6	(105.5)
Other, net	(15.7)	8.0	11.5
Net cash provided by operating activities	546.6	798.1	660.0
Cash flows from investing activities:
Capital expenditures	(100.3)	(102.9)	(126.6)
Change in restricted cash	(121.1)	(31.2)	(31.2)
Payments made for purchases of businesses, net of cash acquired	(202.8)	(97.4)	0.0
Payments made for intangibles	(0.9)	(0.9)	(13.3)
Proceeds from sale of financial instruments and other investments	0.0	21.0	7.1
Other	1.2	0.0	0.7
Net cash used in investing activities	(423.9)	(211.4)	(163.3)
Cash flows from financing activities:
Change in short-term borrowings, net	0.0	(78.0)	78.0
Proceeds from issuance of long-term debt, net	495.6	0.0	0.0
Payments of long-term debt	(250.0)	(4.0)	0.0
Proceeds from exercises under share-based compensation plans, net	50.9	58.7	98.4
Excess tax benefit relating to share-based compensation plans	41.4	44.2	35.2
Purchases of common stock	(406.9)	(498.7)	(659.6)
Dividends paid	(74.6)	(69.4)	(66.2)
Payments of contingent and deferred consideration	(6.2)	(6.9)	(70.2)
Net cash used in financing activities	(149.8)	(554.1)	(584.4)
Effect of exchange rate changes on cash and cash equivalents	(18.4)	(42.2)	(19.1)
Decrease in cash and cash equivalents during the year	(45.5)	(9.6)	(106.8)
Balance at January 1	950.5	960.1	1,066.9
Balance at December 31	905.0	950.5	960.1
Cash paid for:
Interest	50.2	42.8	42.7
Income taxes	169.2	192.3	248.5
Non-cash transactions:
Dividends declared, not paid	19.3	18.0	16.8
Purchases of businesses and related costs	$ 17.1	$ 69.0	$ 3.0